Log in

OTCMKTS:LNXSFLanxess Stock Price, Forecast & News

$54.20
+1.10 (+2.07 %)
(As of 07/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$54.20
Now: $54.20▼
$54.20
50-Day Range
$46.80
MA: $52.52▼
$58.35
52-Week Range
$28.34
Now: $54.20▼
$71.08
Volume246 shs
Average Volume1,068 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals. The Specialty Additives segment provides additives, including lubricants, flame retardants, plasticizers, and bromine derivatives for various applications in the rubber, plastic, and paint industries. The Performance Chemicals segment offers material protection products; and inorganic pigments for the coloring of concrete, and emulsion paint and other coatings. It also offers finishing agents for the leather industry; and reverse osmosis membranes and ion exchange resins for water treatment, as well as disinfectant and hygiene solutions. The Engineering Materials segment produces technical plastics, glass fibers, fiber composites, and elastomers on a urethane basis for application in the automotive and electrical/electronics, and construction and medicine industries, as well as sports and leisure sectors. The ARLANXEO segment provides specialty rubbers for use in high-quality rubber products in the automotive engineering, tires, and construction industries. The company was founded in 1863 and is headquartered in Cologne, Germany.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Chemicals: Major Diversified
Sub-IndustryN/A
SectorProcess Industries
Current SymbolOTCMKTS:LNXSF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.lanxess.com
Phone(492) 218-8850

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees14,649
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
OTC:LNXSF Rates by TradingView

Receive LNXSF News and Ratings via Email

Sign-up to receive the latest news and ratings for LNXSF and its competitors with MarketBeat's FREE daily newsletter.

Lanxess (OTCMKTS:LNXSF) Frequently Asked Questions

How has Lanxess' stock been impacted by COVID-19 (Coronavirus)?

Lanxess' stock was trading at $46.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LNXSF stock has increased by 17.8% and is now trading at $54.2010. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Lanxess?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lanxess in the last year. There are currently 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Lanxess.

What are Wall Street analysts saying about Lanxess stock?

Here are some recent quotes from research analysts about Lanxess stock:
  • 1. UBS Group AG analysts commented, "ZuRICH (dpa-AFX Analyser) – Die Schweizer Grossbank UBS hat das Kursziel fur Lanxess von 56 auf 43 Euro gesenkt, aber die Einstufung auf Neutral" belassen. Wegen erwarteter Belastungen durch die Corona-Krise habe er seine 2020er Umsatz- und Ergebnisprognosen (EPS) fur die europaischen Chemiekonzerne um durchschnittlich 10 beziehungsweise 27 Prozent reduziert, schrieb Analyst Andrew Stott in einer am Donnerstag vorliegenden Branchenstudie. Beim EPS liege er damit rund 14 Prozent unter den durchschnittlichen Analystenschatzungen. Mit einer Nachfrage-Normalisierung im Sektor rechnet er erst im vierten Quartal 2020./edh/bek Veroffentlichung der Original-Studie: 09.04.2020 / 01:08 / GMT Erstmalige Weitergabe der Original-Studie: 09.04.2020 / Uhrzeit in Studie nicht angegeben / GMT Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, Art. 20 VO (EU) 596/2014 fur das genannte Analysten-Haus finden Sie unter http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html." (4/9/2020)
  • 2. Baader Bank analysts commented, "MuNCHEN (dpa-AFX Analyser) – Die Baader Bank hat Lanxess von Add" auf Buy" hochgestuft, das Kursziel aber von 60 auf 46 Euro gesenkt. Den europaischen Chemieunternehmen stehe in den kommenden drei bis vier Monaten wegen der Covid-19-Pandemie ein herber Abschwung bevor, schrieb Analyst Markus Mayer in einer am Montag vorliegenden Branchenstudie. Im Gegensatz zur Zeit der Finanzkrise in den Jahren 2008 und 2009 aber sei Lanxess nun defensiver aufgestellt und durfte damit deutlich weniger anfallig fur zyklische Schwankungen sein. Zudem konnten die Aktien von der starken Bilanz des Unternehmens profitieren./la/he Veroffentlichung der Original-Studie: 06.04.2020 / 17:24 / CEST Erstmalige Weitergabe der Original-Studie: Datum in Studie nicht angegeben / / CEST Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, Art. 20 VO (EU) 596/2014 fur das genannte Analysten-Haus finden Sie unter http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html." (4/7/2020)
  • 3. HSBC Holdings plc analysts commented, "LONDON (dpa-AFX Analyser) – Die britische Investmentbank HSBC hat das Kursziel fur Lanxess von 88 auf 67 Euro gesenkt, die Einstufung jedoch auf Buy" belassen. Noch mindestens bis Mitte des Jahres durften die Schatzungen fur die europaischen Chemieproduzenten sinken, schrieb Analyst Martin Evans in einer am Freitag vorliegenden Branchenstudie. Bis dahin sollten Anleger vor allem auf die Liquiditat der Unternehmen schauen. Nach dem Verkauf des Polybutadien-Geschafts an Saudi Aramco sei die Kapitalausstattung von Lanxess stark./bek/jha/ Veroffentlichung der Original-Studie: 01.04.2020 / 14:59 / GMT Erstmalige Weitergabe der Original-Studie: 02.04.2020 / Uhrzeit in Studie nicht angegeben / Zeitzone in Studie nicht angegeben Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, Art. 20 VO (EU) 596/2014 fur das genannte Analysten-Haus finden Sie unter http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html." (4/6/2020)

Has Lanxess been receiving favorable news coverage?

Headlines about LNXSF stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Lanxess earned a daily sentiment score of -2.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the company's share price in the immediate future. View the latest news about Lanxess.

Who are some of Lanxess' key competitors?

Who are Lanxess' key executives?

Lanxess' management team includes the following people:
  • Mr. Matthias Zachert, Chairman of Management & CEO (Age 52)
  • Mr. Michael Pontzen, CFO & Member of the Board of Management (Age 50)
  • Dr. Rainier van Roessel, Labor Relations Director & Member of the Board of Management (Age 62)
  • Dr. Hubert Fink, Member of the Board of Management (Age 57)
  • André Simon, Head of Investor Relations

What is Lanxess' stock symbol?

Lanxess trades on the OTCMKTS under the ticker symbol "LNXSF."

How do I buy shares of Lanxess?

Shares of LNXSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lanxess' stock price today?

One share of LNXSF stock can currently be purchased for approximately $54.20.

What is Lanxess' official website?

The official website for Lanxess is www.lanxess.com.

How can I contact Lanxess?

The company can be reached via phone at (492) 218-8850.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.